title: How to best define target populations of medicines in view of their coverage by the national health insurance scheme?
abstract: The target population of a medicine may include different populations that may partially overlap including the population that has been evaluated in the clinical trials, the population for which the medicine provides an actual benefit (SMR), that for which the drug provides an improvement of the actual benefit (ASMR), etc. The definition of the target population in both qualitative and quantitative terms has key public health and economic implications. Recommendations are made to shed light on the definitions, to clarify the requests of the public decision makers and to improve the methods and the sources allowing the quantification of target populations.
authors.affiliation: Service Evaluation Economique et de Santé Publique, Haute Autorité de Santé, Saint-Denis La Plaine Cedex, France.
authors.forename: Françoise F
authors.initials: FF
authors.lastname: Hamers
authors.forename: Jacques
authors.initials: J
authors.lastname: Massol
authors.forename: Patricia
authors.initials: P
authors.lastname: Maillère
mesh_terms: D004358:Drug Therapy / Q000592:standards*; D005602:France; D017408:Guidelines as Topic; D006301:Health Services Needs and Demand; D006801:Humans; D009313:National Health Programs / Q000592:standards*; D011153:Population